Unknown

Dataset Information

0

Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.


ABSTRACT: While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target delivery. The nanoparticle is composed of three magnetic nanospheres and one doxorubicin-loaded liposome assembled in a 100 nm long chain. These nanoparticles display prolonged blood circulation and significant intratumoral deposition in tumor models in rodents. Furthermore, the magnetic particles of the chains serve as a mechanical transducer to transfer radio frequency energy to the drug-loaded liposome. The defects on the liposomal walls trigger the release of free drug capable of spreading throughout the entire tumor, which results in a widespread anticancer effect.

SUBMITTER: Peiris PM 

PROVIDER: S-EPMC3358486 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

Peiris Pubudu M PM   Bauer Lisa L   Toy Randall R   Tran Emily E   Pansky Jenna J   Doolittle Elizabeth E   Schmidt Erik E   Hayden Elliott E   Mayer Aaron A   Keri Ruth A RA   Griswold Mark A MA   Karathanasis Efstathios E  

ACS nano 20120413 5


While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target  ...[more]

Similar Datasets

| S-EPMC3751936 | biostudies-other
| S-EPMC9007990 | biostudies-literature
| S-EPMC3099449 | biostudies-literature
| S-EPMC5469743 | biostudies-other
| S-EPMC3739802 | biostudies-other
| S-EPMC5757354 | biostudies-literature
| S-EPMC7776621 | biostudies-literature
| S-EPMC5295417 | biostudies-literature
| S-EPMC10059094 | biostudies-literature
| S-EPMC8501031 | biostudies-literature